Skip to main content

BBI Ph1 TP-3654 and Ruxolitinb in patients with Intermediate and High Risk Myelofibrosis

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Sumitomo Dainippon Pharma Co.

Start Date

February 28, 2020

End Date

March 31, 2025
 

Administered By

Duke Cancer Institute

Awarded By

Sumitomo Dainippon Pharma Co.

Start Date

February 28, 2020

End Date

March 31, 2025